A prospective study on comprehensive sampling to search exacerbation factors and efficacy predictors in patients with autoimmune and immune related disease

A prospective study on comprehensive sampling to search exacerbation factors and efficacy predictors in patients with autoimmune and immune related disease - comprehensive sampling in patients with autoimmune and immune related disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041268

Enrollment

100

Registered

2020-08-01

Start date

2019-09-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with autoimmune/immune-related diseases such as ulcerative colitis, Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria for each disease 2. Patients who obtained written consent

Exclusion criteria

Exclusion criteria: 1. Patients who have not confirmed the diagnosis 2. Patients who do not get written consent 3. Patients who the doctor judges as inappropriate

Design outcomes

Primary

Measure	Time frame
Expression of inflammatory cytokines in the intestinal tract, analysis of intestinal bacterial flora, measurement of fecal metabolites, identification of disease susceptibility genes	—

Countries

Japan

Contacts

Public ContactYoshihiro Yokoyama

Sapporo Medical University School of Medicine Department of Gastroenterology and Hepatology

yoshi_yokoyamaa@yahoo.co.jp0116112111

Outcome results